Drug intelligence / Profile preview

autologous adipose-derived stromal vascular fraction (Fodor)

Development stage: Unknown
Lead developer: Peter B. Fodor
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraarticular

Overview

This autologous cell therapy involves the use of the stromal vascular fraction (SVF) derived from a patient's own adipose tissue. Developed by Dr. Peter B. Fodor, the procedure utilizes enzymatic disaggregation of lipoaspirate to isolate a heterogeneous cell population that includes mesenchymal stem cells, endothelial progenitor cells, and leukocytes. The therapy is administered via a single intra-articular injection into the knee joint, specifically targeting patients with Grade I-III osteoarthritis. It is designed to leverage the regenerative, anti-inflammatory, and immunomodulatory properties of the stromal cells to reduce pain and improve joint function.

Other names: ADSCSVFadipose-derived stromal cellsstromal vascular fractionautologous adipose-derived stromal vascular cells

Beyond the preview

Go deeper on autologous adipose-derived stromal vascular fraction (Fodor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous adipose-derived stromal vascular fraction (Fodor).

Explore the full profile